TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer
Authors
Keywords
Tumor necrosis factor alpha, Tumor necrosis factor receptor 1, Tumor necrosis factor receptor 2, Intracystic fluid, Ovarian neoplasm, Prognostic factor
Journal
CLINICAL AND EXPERIMENTAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-25
DOI
10.1007/s10238-018-0508-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
- (2017) Nirmala Chandralega Kampan et al. Frontiers in Immunology
- TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
- (2016) Mamta Gupta et al. HUMAN PATHOLOGY
- The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer
- (2015) Fang Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Correlation of cytokines and inducible nitric oxide synthase expression with prognostic factors in ovarian cancer
- (2014) Agrimaldo Martins Filho et al. IMMUNOLOGY LETTERS
- Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells
- (2014) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants
- (2014) Sharath P. Sasi et al. PLoS One
- Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment
- (2013) Chindu Govindaraj et al. CLINICAL IMMUNOLOGY
- The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and Its Associated Research Resource
- (2013) C. S. Zhu et al. JNCI-Journal of the National Cancer Institute
- Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
- (2012) Aleksandra Mielczarek-Palacz et al. Archives of Medical Science
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Breaking the ‘harmony’ of TNF-α signaling for cancer treatment
- (2011) S P Sasi et al. ONCOGENE
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Molecular typing of epithelial ovarian carcinomas using inflammatory markers
- (2010) Rouba Ali-Fehmi et al. CANCER
- The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
- (2009) Kellie A. Charles et al. JOURNAL OF CLINICAL INVESTIGATION
- Production of Cytokines During Interaction of Peripheral Blood Mononuclear Cells with Autologous Ovarian Cancer Cells or Benign Ovarian Tumour Cells
- (2009) M. Nowak et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- TNF: A master switch for inflammation to cancer
- (2008) Gautam Sethi Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now